OakChart

Supernus Inc

SUPNHealthcare·Drug Manufacturers - Specialty & Generic·USA·Mid·NASD·Nov 11 • 3:59 PM ET

29.45+0.70 (2.43%)
2026-11-12 02:08 CET
Market cap
3,587.14 USD m
Revenue, TTM
1,374.00 USD m
Net income, TTM
450.00 USD m
Free cash flow, TTM
25.96 USD m
EPS diluted, TTM
3.61
P/E
8.15
Compare

Price

SUPN against its 20, 50 and 200-day averages
2050200beat
25.0027.5030.0032.504.8M9.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SUPNclose 29.4520-day 27.2250-day 27.36200-day 27.7629.4552w high

11.3% under the 52-week high of 33.22 on 26 Jun 2026. 52-week low 21.48 on 24 Mar 2026. Last 15 sessions, 22.0% high to low

Volume 0.94× normal · the line is the 50-bar volume average

Profile

SUPN
52-week range, 68% of the way up
21.4833.22

Supernus, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of treatments for patients living with central nervous system (CNS) diseases. Its portfolio includes treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. The company was founded in 2005 and is headquartered in Rockville, MD.

IndexRUT
Employees838
IPOMay 01, 2012
Beta-0.58
ATR, 14d1.33
Rel volume0.94
Short float3.82%
Insider own3.00%
Inst own97.31%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap6.12B
Enterprise Value6.31B
Income450.00M
Sales1.37B
Book/sh-0.51
Cash/sh1.47
Dividend Est.-
Dividend TTM-
Dividend Ex-DateNov 03, 2026
Dividend Gr. 3/5Y- -
Payout0.00%
Employees838
IPOMay 01, 2012

Ratios

P/E8.15
Forward P/E7.58
PEG0.36
P/S4.45
P/B-
P/C20.06
P/FCF235.65
EV/EBITDA9.97
EV/Sales4.59
Quick Ratio0.50
Current Ratio0.62
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)3.61
EPS next Y3.88
EPS next Q0.87
EPS this Y23.53%
EPS next Y25.75%
EPS next 5Y20.92%
EPS past 3/5Y- -
Sales past 3/5Y11.20% 13.88%
EPS Y/Y TTM265.06%
Sales Y/Y TTM16.44%
EPS Q/Q244.87%
Sales Q/Q13.38%
EarningsOct 29 BMO
EPS/Sales Surpr.24.45% 8.09%

Ownership

Insider Own3.00%
Insider Trans0.00%
Inst Own97.31%
Inst Trans-4.51%
ROA32.75%
ROE-
ROIC-
Gross Margin85.08%
Oper. Margin45.05%
Profit Margin32.75%
SMA208.19%
SMA507.65%
SMA2006.10%
Trades-

Technical

Shs Outstand124.77M
Shs Float121.03M
Short Float3.82%
Short Ratio1.42
Short Interest4.62M
52W High33.22 -11.34%
52W Low21.48 37.12%
Volatility5.77% 5.12%
ATR (14)1.33
RSI (14)62.98
Beta-0.58
Rel Volume0.94
Avg Volume3.25M
Volume3,072,523

Performance

Perf Week4.40%
Perf Month7.16%
Perf Quarter-0.69%
Perf Half Y-1.03%
Perf YTD5.78%
Perf Year22.16%
Perf 3Y137.74%
Perf 5Y137.22%
Perf 10Y36.34%
Recom1.33
Target Price45.67
Prev Close28.75
Price29.45
Change %2.43%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 09, 2026InitiatedBBofA SecuritiesBuy$47+59.6%
Nov 04, 2026ResumedPPiper SandlerOverweight$47+59.6%
Oct 09, 2025UpgradePPiper SandlerNeutral → Overweight$65+120.7%
Jul 30, 2025UpgradeCCantor FitzgeraldNeutral → Overweight$42+42.6%
Feb 19, 2025DowngradeCCantor FitzgeraldOverweight → Neutral$57 → $36+22.2%
Jan 06, 2025InitiatedCCantor FitzgeraldOverweight$57+93.5%
Sep 11, 2024DowngradePPiper SandlerOverweight → Neutral$41 → $36+22.2%
Jan 03, 2023ResumedJJefferiesBuy$44 → $45+52.8%
Dec 01, 2021ResumedJJefferiesBuy$40 → $44+49.4%
Apr 13, 2021UpgradeJJefferiesHold → Buy$25 → $40+35.8%

Peers

Mkt cap
TickerCompanyMkt cap
ALKSAlkermes plc8.05B
NBIXNeurocrine Biosciences Inc17.65B
ACADAcadia Pharmaceuticals Inc3.17B
AXSMAxsome Therapeutics Inc7.85B
COLLCollegium Pharmaceutical Inc770.99M
HRMYHarmony Biosciences Holdings Inc2.01B
INDVIndivior Pharmaceuticals Inc5.97B
JAZZJazz Pharmaceuticals plc15.93B
AMRXAmneal Pharmaceuticals Inc7.56B
BIIBBiogen Inc37.46B

Insider trading

latest 14 of 43
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Khattar Jack A.President, CEOAug 12 '26Option Exercise0.0029,84901,270,993Aug 14 05:12 PM
Rubin JonathanSVP, Chief Medical OfficerAug 12 '26Option Exercise0.00750014,342Aug 14 05:11 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOAug 12 '26Option Exercise0.002,500019,795Aug 14 05:11 PM
Mottola FrankSVP, Chief Tech. Ops. OfficerAug 12 '26Option Exercise0.001,650020,341Aug 14 05:10 PM
DEC TIMOTHY CSenior Vice-President & CFOAug 12 '26Option Exercise0.001,25009,733Aug 14 05:09 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 17 '26Option Exercise38.5150,0001,925,53767,044Mar 18 05:18 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 16 '26Option Exercise33.6250,0001,681,20567,044Mar 18 05:18 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 18 '26Option Exercise39.407,250285,65024,294Mar 18 05:18 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 17 '26Sale50.3050,0002,514,88617,044Mar 18 05:18 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 16 '26Sale50.2850,0002,513,92517,044Mar 18 05:18 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 18 '26Sale49.607,250359,62117,044Mar 18 05:18 PM
PADMANABH P BHATTOfficerMar 17 '26Proposed Sale50.2157,2502,874,522Mar 17 04:29 PM
PADMANABH P BHATTOfficerMar 16 '26Proposed Sale49.9150,0002,495,500Mar 16 04:38 PM
Khattar Jack A.President, CEOMar 13 '26Sale50.3735,0001,763,124958,100Mar 16 04:08 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IJTiShares S&P Small-Cap 600 Growth ETFAUM: 7.45B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200
  • Supernus, Inc. to Participate in the 2026 Jefferies Global Healthcare Conference in London (GlobeNewswire)
  • Supernus undervalued after Indivior merger, says Bank of America (Proactive) +5.58%
  • Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader (GlobeNewswire)
  • Supernus Ends Its Standalone Era With A Big Beat And Higher Guidance, But The Indivior Merger Now Drives The Story (Earnings Whispers)
  • Supernus: Q3 Earnings Snapshot (Associated Press)
  • Supernus Announces Third Quarter 2026 Financial Results (GlobeNewswire)
  • Updated Effective Date: Huron Consulting Group Set to Join S&P SmallCap 600 (PR Newswire)
  • Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree for 'Ms. Represented' Campaign (GlobeNewswire)
  • Huron Consulting stock rises on S&P SmallCap 600 addition (Investing.com)
  • MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600 (PR Newswire)
  • Supernus Must Prove Its Standalone Engine Still Hums As Indivior Merger Nears (Earnings Whispers)
  • Supernus Announces Orphan Drug Exclusivity for ONAPGO (apomorphine HCl) (GlobeNewswire)
  • Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026 (GlobeNewswire)
  • Are ITGR, BZH, SUPN Obtaining Fair Deals for their Shareholders? (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-291.3201.0611.120356329.353
2026Q22026-08-030.5260.4230.984219.06205.314
2026Q12026-05-050.6020.2980.690207.71192.924
2025Q42026-02-240.8460.3400.816211.57195.164
2025Q32025-11-041.0050.5900.326192.1180.224
2025Q22025-08-050.9080.4700.143165.45154.063
2025Q12025-05-060.4380.3730.376149.82147.943
2024Q42025-02-250.7460.5200.160174.16155.253
2024Q32024-11-041.1680.4430.030175.69157.353
2024Q22024-08-060.7710.390-0.794168.33148.833
2024Q12024-05-080.0000.2630.339143.64145.834
2023Q42024-02-270.8830.5530.380164.31155.033
2023Q32023-11-08-0.2900.005-0.980153.88146.172
2023Q22023-08-08-0.0200.2100.273135.56143.633
2023Q12023-05-090.2900.3070.312153.76139.023
2022Q42023-02-280.4300.673-1.341167.33180.334

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY2.1002.1200.887392.76399.28
2020FY2.3602.468-1.010520.4523.01
2021FY0.9801.3931.329579.78579.8
2022FY1.0402.153-0.381667.24680.28
2023FY2.3511.983-0.942607.52598.26
2024FY3.1432.8730.053661.82642.9
2025FY2.5002.3531.6401,2391,191
2026FY-3.088--1,694
2027FY-3.884--2,414
2028FY-4.420--2,582
2029FY-5.350--2,835
2030FY-5.930--2,986

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-11200532.36468596.71
2026Q4S2026-11-09400435.13331.5596.71
2026Q4S2026-11-02300381.27331.5468
2026Q4S2026-10-30302230.85226.4237.47
2026Q4S2026-10-29200337.9331.5344.3
2026Q4S2026-10-21302229.65224.2237.47
2026Q4S2026-10-20402230.44224.2237.47
2026Q4S2026-10-17200337.9331.5344.3
2026Q4S2026-10-15421235.31227.29243.7
2026Q4S2026-08-07421236.92232.8243.7
2026Q4S2026-08-03220337.9331.5344.3
2026Q4S2026-07-31310321.17308.2331
2026Q4S2026-07-24600234.93232.8237.3
2026Q4S2026-07-20600235.08232.8238.2

Estimate history

EPS, annual0.41.8310.887-1.011.329-0.381-0.9420.0531.6413.6127
Period201720182019202020212022202320242025TTM
EPS, quarterly0.030.160.3760.1430.3260.8160.690.9841.123
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual109310057856477919011093118812391374
Period201720182019202020212022202320242025TTM
Sales, quarterly307298266302314358317343356
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual144.293145.688146.158146.727140.488136.481137125125118
Period201720182019202020212022202320242025MRQ
Shares, quarterly129.575125125125125125122118118
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,374.001,239.001,188.001,093.00901.00791.00647.00785.001,005.00
Cost of Goods Sold Incl. D&A205.00223.00211.00174.00172.00140.00109.00159.00141.00
Gross Profit1,169.001,016.00977.00919.00729.00651.00538.00626.00864.00
Selling, General and Administrative Excl. Other550.00658.00707.00685.00520.00464.00450.00424.00532.00
Research and Development33.0080.00107.00116.0072.0052.0040.0053.0067.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income619.00358.00270.00234.00209.00187.0088.00202.00332.00
Interest Expense18.0045.0041.0035.0029.0026.0026.0020.0031.00
Unusual Expense87.00105.00228.00401.00297.00-5.00244.0026.0040.00
Net Income Before Taxes538.00239.0020.00-149.00-95.00190.00-173.00180.00278.00
Income Taxes88.0029.0013.00-20.00-42.00-15.00-25.0046.003.00
Consolidated Net Income450.00210.007.00-129.00-53.00205.00-148.00134.00275.00
Net Income From Continuing Operations450.00210.007.00-129.00-53.00205.00-148.00134.00275.00
Net Income450.00210.007.00-129.00-53.00205.00-148.00134.00275.00
EPS (Recurring)4.192.211.251.111.111.310.161.012.02
EPS (Basic, Before Extraordinaries)3.721.680.05-0.94-0.381.41-1.010.921.89
EPS (Diluted)3.611.640.05-0.94-0.381.33-1.010.891.83
EBITDA633.00378.00298.00249.00230.00209.00114.00230.00348.00
Non-Operating Income (Expense)23.0031.0019.0052.0022.0024.009.0024.0017.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense25.8724.0019.0015.7512.968.916.482.4312.15
Price To Earnings Ratio7.967.96--14.289.54-2.202.72
Price To Sales Ratio3.183.711.391.913.453.361.660.501.01
Gross Margin85.0882.0082.2484.0880.9182.3083.1579.7585.97
Operating Margin45.0528.8922.7321.4123.2023.6413.6025.7333.03
Net Margin32.7516.950.59-11.80-5.8825.92-22.8717.0727.36
Shares Outstanding118.00125.00125.00137.00136.48140.49146.73146.16145.69
Market Capitalization3,587.143,587.141,208.191,618.802,303.541,880.35833.93294.85763.03

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue356.00343.00317.00358.00314.00302.00266.00298.00
Cost of Goods Sold Incl. D&A51.0050.0040.0064.0062.0052.0044.007.00
Gross Profit305.00293.00277.00294.00252.00250.00222.00291.00
Selling, General and Administrative Excl. Other119.00128.00131.00172.00153.00179.00154.00196.00
Research and Development0.007.009.0017.0020.0021.0022.0031.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income186.00165.00146.00122.0099.0071.0068.0095.00
Interest Expense2.002.007.006.0012.0015.0012.0013.00
Unusual Expense6.006.0027.0048.0056.000.001.0052.00
Net Income Before Taxes182.00160.00115.0081.0037.0062.0059.0036.00
Income Taxes45.0038.0026.00-21.00-5.0044.0011.0016.00
Consolidated Net Income137.00122.0089.00102.0042.0018.0047.0020.00
Net Income From Continuing Operations137.00122.0089.00102.0042.0018.0047.0020.00
Net Income137.00122.0089.00102.0042.0018.0047.0020.00
EPS (Recurring)1.161.020.841.080.630.140.380.45
EPS (Basic, Before Extraordinaries)1.161.030.720.820.340.140.380.16
EPS (Diluted)1.120.980.690.820.330.140.380.16
EBITDA188.00168.00150.00127.00104.0074.0073.0099.64
Non-Operating Income (Expense)4.003.003.0013.007.006.004.005.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.328.697.113.754.746.325.00-
Price To Earnings Ratio7.9616.1214.2427.7226.39---
Price To Sales Ratio3.183.823.053.622.641.581.021.31
Gross Margin85.6785.4287.3882.1280.2582.7883.4697.65
Operating Margin52.2548.1046.0634.0831.5323.5125.5631.88
Net Margin38.4835.5728.0828.4913.385.9617.676.71
Shares Outstanding118.00118.00122.00125.00125.00125.00125.00125.00
Market Capitalization3,587.143,972.122,950.783,473.552,334.091,426.98921.761,208.19

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments195.00320.00410.00893.001,102.00858.001,060.00924.00863.00
Short Term Receivables255.00287.00254.00225.00215.00219.00204.00318.00295.00
Inventories153.00167.00135.00114.0095.0093.0073.0078.0052.00
Other Current Assets49.0053.00467.0027.0032.0017.0023.009.0015.00
Total Current Assets652.00827.001,266.001,259.001,444.001,187.001,360.001,329.001,225.00
Net Property, Plant & Equipment170.00139.00124.0085.0095.00103.00107.0057.0054.00
Total Investments and Advances28.0027.0041.0098.000.000.000.000.000.00
Long-Term Note Receivable-------33.0015.00
Intangible Assets2.006.0013.0070.0082.0062.0072.0084.0092.00
Deferred Tax Assets326.00283.00293.00219.00105.0075.0040.0044.0058.00
Other Assets26.0040.0028.0038.00106.00104.0073.000.000.00
Total Assets1,204.001,322.001,765.001,769.001,832.001,531.001,652.001,547.001,444.00
Short Term Debt Incl. Current Port. of LT Debt39.0028.0012.0011.0011.0012.009.004.005.00
Accounts Payable48.0063.0039.0036.00573.00416.00499.00557.00473.00
Income Tax Payable2.007.008.009.007.0015.0039.0024.0041.00
Other Current Liabilities825.00826.001,231.00963.00213.00156.00195.00233.00335.00
Total Current Liabilities914.00924.001,290.001,019.00804.00599.00742.00818.00854.00
Long Term Debt312.00347.00271.00266.00275.00273.00284.00237.00477.00
Provision for Risks Charges0.000.000.005.0076.0051.00417.00424.00316.00
Deferred Tax Liabilities3.006.005.00------
Other Liabilities73.00382.00390.00428.00474.00526.000.002.000.00
Total Liabilities1,302.001,659.001,956.001,718.001,629.001,449.001,443.001,481.001,647.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-98.00-337.00-191.0051.00203.0082.00209.0066.00-203.00
Total Shareholders Equity-98.00-337.00-191.0051.00203.0082.00209.0066.00-203.00
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity-98.00-337.00-191.0051.00203.0082.00209.0066.00-203.00
Total Liabilities & Stockholders Equity1,204.001,322.001,765.001,769.001,832.001,531.001,652.001,547.001,444.00
Book Value Per Share-0.78-2.70-1.390.371.440.561.430.45-1.41
Tangible Book Value Per Share-0.80-2.74-1.49-0.140.860.140.94-0.12-2.04
Full-Time Employees8381,0511,1649538857887969151,023
Price to Book Ratio-56.54-7.48-68.1010.249.2610.171.4111.56-41.60
Return on Assets16.610.45-7.30-2.9412.19-9.308.3818.394.37
Return on Equity--7.84-41.73143.86-101.7297.45--
Return on Invested Capital98.1370.00-161.25-16.7242.89-41.6927.1890.7621.17
Quick Ratio0.550.710.881.121.681.831.731.531.37
Current Ratio0.710.900.981.241.801.981.831.621.43

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income448.84210.007.00-129.00-85.00213.00-156.00178.00292.00
Depreciation13.7820.0028.0015.0021.0022.0026.0028.0016.00
Other Funds (Non Cash)68.4046.0040.00173.00-65.00-55.00-44.0024.00-34.00
Funds from Operations527.79230.0082.00-6.00-129.00180.00-174.00230.00274.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-437.37-257.00-46.00-294.00125.00173.00-19.00-79.0029.00
Cash from Operating Activities90.42-27.0036.00-300.00-4.00353.00-193.00151.00303.00
Capital Expenditures-64.45-67.00-31.00-53.00-6.00-34.00-4.00-7.00-41.00
Net Assets From Acquisitions0.000.000.00-129.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments1.011.00100.0084.00-218.000.000.000.000.00
Purchase of Investments-17.80-20.00-17.00-45.00-245.000.000.000.000.00
Sale Or Maturity of Investments18.8121.00117.00129.0027.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.003.001.0020.000.005.0037.00
Cash from Investing Activities-63.44-66.0069.00-95.00-223.00-14.00-4.00-2.00-4.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-301.65-9.00-170.00-30.00-88.00-100.001.000.003.00
Repurchase of Common Pref Stock-301.62-11.00-173.00-33.00-90.00-101.000.000.000.00
Sale of Common Pref Stock-0.032.003.003.002.001.001.000.003.00
Proceedsfrom Stock Options-0.032.003.003.002.001.001.000.003.00
Issuance or Reduction of Debt, Net0.00-17.0092.00-12.00-3.0014.00-4.00-4.00-240.00
Change in Long Term Debt0.000.000.000.000.000.000.000.00-
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00-
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00-
Net Financing Active Other Cash Flow-15.95-4.00-24.00-22.000.000.000.000.000.00
Other Financing Activities Uses-21.94-4.00-24.00-22.000.000.000.000.000.00
Cash from Financing Activities-171.53-30.00-102.00-64.00-100.00-94.00-10.00-13.00-237.00
Exchange Rate Effect0.02-1.000.001.00-1.00-1.005.000.00-1.00
Net Change in Cash-145.56-124.003.00-458.00-328.00244.00-202.00136.0061.00
Free Cash Flow25.96-93.007.00-308.00-9.00349.00-197.00144.00292.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow168.49-236.17--7.62-2.733.47
Deferred Taxes & Investment Tax Credit--46.007.00-65.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments305.00222.00175.00195.00445.00510.00
Short Term Receivables286.00287.00285.00255.00272.00243.00
Inventories149.00150.00152.00153.00155.00149.00
Other Current Assets61.0068.0055.0049.0049.0048.00
Total Current Assets801.00725.00667.00652.00921.00951.00
Net Property, Plant & Equipment187.00183.00179.00170.00154.00152.00
Total Investments and Advances27.0027.0027.0028.0028.0027.00
Intangible Assets2.002.002.002.002.007.00
Deferred Tax Assets288.00271.00296.00326.00285.00270.00
Other Assets27.0024.0026.0026.0027.0044.00
Total Assets1,332.001,233.001,197.001,204.001,416.001,452.00
Short Term Debt Incl. Current Port. of LT Debt495.009.009.0039.0028.0029.00
Accounts Payable28.0030.0035.0048.0041.0050.00
Income Tax Payable63.0030.0026.002.004.0017.00
Other Current Liabilities715.00799.00709.00825.00892.00960.00
Total Current Liabilities1,301.00868.00779.00914.00965.001,056.00
Long Term Debt6.00500.00500.00312.00328.00337.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---3.00--
Other Liabilities85.0073.0062.0073.00330.00317.00
Total Liabilities1,392.001,441.001,341.001,302.001,623.001,710.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-60.00-208.00-144.00-98.00-207.00-257.00
Total Shareholders Equity-60.00-208.00-144.00-98.00-207.00-257.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-60.00-208.00-144.00-98.00-207.00-257.00
Total Liabilities & Stockholders Equity1,332.001,233.001,197.001,204.001,416.001,453.00
Book Value Per Share-0.51-1.76-1.18-0.78-1.66-2.06
Tangible Book Value Per Share-0.53-1.78-1.20-0.80-1.67-2.11
Full-Time Employees---838--
Price to Book Ratio-56.54-26.97-30.17-16.81-9.10-5.02
Return on Assets32.7526.4419.5216.538.825.96
Return on Invested Capital-41.7825.0047.6634.7122.50
Quick Ratio0.500.660.660.550.790.76
Current Ratio0.620.840.860.710.950.90

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income137.24121.5489.00101.0643.9419.92
Depreciation2.012.984.004.795.105.30
Other Funds (Non Cash)11.0714.8934.008.4426.653.33
Funds from Operations133.40164.31154.0076.0858.2139.81
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-36.1364.21-163.00-302.45-100.00126.11
Cash from Operating Activities97.28228.52-9.00-226.38-41.78165.91
Capital Expenditures-14.03-6.94-20.00-23.47-20.46-18.68
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-1.00-0.001.001.010.00-1.00
Purchase of Investments-4.01-2.98-5.00-5.81-3.05-6.33
Sale Or Maturity of Investments3.012.986.006.823.055.33
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-14.03-7.94-19.00-22.46-20.46-18.68
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.46-175.35-126.000.161.06-0.30
Repurchase of Common Pref Stock-0.46-175.35-126.000.190.03-0.33
Sale of Common Pref Stock0.000.000.00-0.031.020.03
Proceedsfrom Stock Options0.000.000.00-0.031.020.03
Issuance or Reduction of Debt, Net0.23-0.33151.00-4.84-4.08-4.24
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.972.03-18.00-0.960.01-0.09
Other Financing Activities Uses-0.030.05-21.00-0.960.01-0.09
Cash from Financing Activities-0.25-172.647.00-5.64-3.01-4.62
Exchange Rate Effect0.000.000.000.02-2.06-
Net Change in Cash82.9947.94-21.00-255.49-65.26142.61
Free Cash Flow83.24221.58-29.00-249.87-62.24148.26
Price to Free Cash Flow168.49---23.129.36

Revenue breakdown

APOKYN2024: 73.93M 2025: 47.77M
Collaboration2025: 53.00M
GOCOVRI2024: 130.82M 2025: 146.82M
Manufactured Product, Other2024: 29.01M 2025: 26.91M
ONAPGO2025: 17.25M
Oxtellar X R2024: 99.46M 2025: 40.70M
Qelbree2024: 241.27M 2025: 304.65M
Royalty, License And Other2024: 24.12M 2025: 39.42M
Trokendi Xr2024: 63.20M 2025: 42.42M
United States2024: 661.82M 2025: 718.95M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.82%4.6M121.0M3.14M
2026-10-157.42%4.0M54.5M768.77K
2026-09-309.14%5.0M54.5M788.63K
2026-09-159.15%5.0M54.5M845.80K
2026-08-318.58%4.7M54.4M846.50K
2026-08-147.62%4.1M54.4M852.01K
2026-07-318.84%4.8M54.5M762.46K
2026-07-158.91%4.9M54.4M775.27K
2026-06-3013.12%7.1M54.4M697.80K
2026-06-1511.23%6.1M54.4M633.25K
2026-05-299.95%5.4M54.4M640.64K
2026-05-158.69%4.7M54.5M724.44K
2026-04-308.60%4.7M54.9M689.58K
2026-04-158.69%4.7M54.5M717.87K
2026-03-318.32%4.5M54.5M738.69K
2026-03-137.69%4.2M54.5M743.89K
2026-02-277.49%4.1M54.5M728.41K
2026-02-137.41%4.0M54.2M671.93K
2026-01-307.33%4.0M54.4M790.95K
2026-01-157.58%4.1M54.4M799.77K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call6.8720.6024.600.0010.6790.000.000.994-0.0210.001
call11.8715.6019.600.006.8640.000.000.990-0.0210.001
call13.8713.6017.600.005.8880.000.000.988-0.0200.001
call14.8712.6016.600.005.4600.000.000.987-0.0200.002
call15.8711.6015.600.005.0641.000.000.986-0.0200.002
call16.8710.6014.600.004.6958.000.000.984-0.0200.002
call17.879.6013.600.004.3481.000.000.983-0.0200.002
call18.878.6012.609.504.0196.000.000.981-0.0200.002
call19.877.6011.600.003.7080.000.000.979-0.0190.002
call20.876.6010.400.003.2421.000.000.977-0.0190.003
call21.875.609.400.002.9648.000.000.974-0.0190.003
call22.874.608.400.002.6961.000.000.787-0.2170.013
call23.873.606.700.001.9082.000.000.766-0.2070.014
call24.872.756.803.232.3828.000.000.743-0.1960.015
call25.871.855.900.002.2475.000.000.715-0.1830.016
call26.871.304.900.001.9792030.000.672-0.2040.017
call27.870.404.402.031.99930.000.000.631-0.2020.017
call28.870.054.000.002.04727.000.000.588-0.2050.018
call29.870.003.500.002.01515.000.000.545-0.2060.018
call30.870.002.400.001.6323160.000.485-0.1790.018
call31.870.002.101.011.66235.000.000.434-0.1740.018
call33.000.002.500.101.8600.002.000.403-0.1880.018
call34.000.002.100.002.0210.000.000.383-0.2010.017
call35.000.002.300.002.0350.000.000.348-0.1950.017
call36.870.000.800.051.7191741.000.234-0.1350.014
call38.000.002.200.001.7070.000.000.205-0.1260.013
call39.000.002.153.201.8210.000.000.196-0.1310.013
call40.000.002.150.001.8790.000.000.191-0.1330.013
call41.870.002.150.003.0534.000.000.304-0.2700.016
call46.870.002.150.002.4583.000.000.158-0.1540.011
call51.870.002.150.002.8014.000.000.144-0.1660.010
put6.870.002.150.004.8150.000.00-0.010-0.0340.001
put11.870.002.150.003.0963.000.00-0.016-0.0330.002
put13.870.002.150.002.6152.000.00-0.020-0.0320.002
put14.870.002.150.002.3992.000.00-0.021-0.0320.002
put15.870.002.150.002.1929.000.00-0.024-0.0310.003
put16.870.002.150.001.98910.000.00-0.026-0.0310.003
put17.870.002.150.001.8289.000.00-0.028-0.0300.003
put18.870.002.150.001.6279.000.00-0.031-0.0290.003
put19.870.002.150.001.49518.000.00-0.034-0.0290.003
put20.870.002.150.001.17012.000.00-0.023-0.0170.003
put21.870.000.050.051.0331243.00-0.026-0.0160.003
put22.870.002.150.202.8489.000.00-0.213-0.2140.013
put23.870.002.200.002.4939.000.00-0.240-0.1950.014
put24.870.002.250.002.3246.000.00-0.256-0.1930.015
put25.870.252.000.402.05819.000.00-0.285-0.1800.016
put26.870.252.601.222.16413.001.00-0.328-0.2000.017
put27.870.152.900.902.06136.000.00-0.369-0.1990.017
put28.870.003.301.781.9962.000.00-0.412-0.2020.018
put29.870.753.802.351.9651.001.00-0.455-0.2030.018
put30.870.754.400.001.9663010.00-0.515-0.1760.018
put31.871.405.000.001.9451.000.00-0.566-0.1700.018
put33.002.355.900.002.0190.000.00-0.597-0.1840.018
put34.003.206.800.002.1260.000.00-0.617-0.1970.017
put35.004.207.700.002.2190.000.00-0.633-0.2090.017
put36.876.009.500.002.4350.000.00-0.784-0.1170.013
put38.007.1010.601.802.5580.000.00-0.795-0.1220.013
put39.008.0011.602.202.6770.000.00-0.803-0.1260.013
put40.008.9012.600.002.7900.000.00-0.810-0.1300.012
put41.8710.9014.400.002.9450.000.00-0.821-0.1370.012
put46.8715.9019.400.003.4070.000.00-0.842-0.1510.011
put51.8720.9024.400.003.7970.000.00-0.856-0.1610.010

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-043Initial statement of beneficial ownership of securities2026-11-02SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-11-028-KCurrent report2026-11-02SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-29425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-158-KCurrent report2026-10-15SEC
2026-10-06425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-068-KCurrent report2026-10-06SEC
2026-09-30SCHEDULE 13GSEC
2026-09-17425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-178-KCurrent report2026-09-16SEC
2026-09-158-KCurrent report2026-09-09SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-03009.00M10
2026-0200228.26K1
2026-010000
2025-12001.04M2
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.16.11%
MILLENNIUM MANAGEMENT LLC6.64%
VANGUARD PORTFOLIO MANAGEMENT LLC5.70%
ARMISTICE CAPITAL, LLC4.56%
VANGUARD CAPITAL MANAGEMENT LLC4.34%
STATE STREET CORP4.24%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.4.10%
DIMENSIONAL FUND ADVISORS LP3.16%
Stephens Investment Management Group LLC2.81%
GEODE CAPITAL MANAGEMENT, LLC2.63%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF6.03%
Nomura Small Cap Core Fund3.30%
BlackRock Advantage Small Cap Core Fund0.42%
AMG GW&K Small Cap Core Fund0.38%
Third Avenue Small-Cap Value Fund0.27%
iShares S&P Small-Cap 600 Value ETF0.27%
Goldman Sachs Small Cap Value Insights Fund0.21%
Avantis U.S. Small Cap Equity ETF0.21%
MOA SMALL CAP VALUE FUND0.18%
JNL Small Cap Index Fund0.16%

OakChart. SUPN. Cached 15 minutes.